BioInvent International AB (publ) (LON:0H22)
London · Delayed Price · Currency is GBP · Price in SEK 31.45
+1.50 (5.01%)
At close: Nov 20, 2025
LON:0H22 Market Cap
LON:0H22 has a market cap or net worth of 162.97 million as of November 21, 2025. Its market cap has decreased by -21.09% in one year.
Market Cap
162.97M
Enterprise Value
108.49M
Revenue
19.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.45
Market Cap Chart
Since June 14, 2001, LON:0H22's market cap has increased from 80.35M to 162.97M, an increase of 102.83%. That is a compound annual growth rate of 2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 162.97M | -11.09% |
| Dec 30, 2024 | 183.30M | 88.74% |
| Dec 29, 2023 | 97.12M | -41.42% |
| Dec 30, 2022 | 165.78M | -25.08% |
| Dec 30, 2021 | 221.27M | 40.59% |
| Dec 30, 2020 | 157.38M | 214.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.30B |
| Haleon | 32.91B |
| Smith & Nephew | 10.56B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.63B |